NSIM
WST icon

North Star Investment Management’s West Pharmaceutical WST Stock Holding History

North Star Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59K Hold
10
– – ﹤0.01% 1320
2026
Q1 		$2.51K Buy
+10
New +$2.49K ﹤0.01% 1371
2023
Q4 		– Sell
-1
Closed -$375 – 1288
2023
Q3 		$375 Hold
1
– – ﹤0.01% 1218
2023
Q2 		$382 Hold
1
– – ﹤0.01% 1233
2023
Q1 		$346 Hold
1
– – ﹤0.01% 1252
2022
Q4 		$235 Buy
+1
New +$237 ﹤0.01% 1273

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

North Star Investment Management's WST Position: Q2 2026 in Review

North Star Investment Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 10 shares worth $3.59K. The position accounts for ﹤0.01% of the portfolio, ranked #1320.

North Star Investment Management first reported a position in WST in Q4 2022 and has held it in 6 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • North Star Investment Management held 10 shares of West Pharmaceutical worth $3.59K as of Q2 2026.
  • North Star Investment Management left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1320 holding.
  • North Star Investment Management first reported a position in West Pharmaceutical in Q4 2022 and has held it in 6 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.